Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Proposed betaARK1 reduction remains investigational in HF; leaves open whether targeted inhibition can restore beta-adrenergic signaling.
β-adrenergic receptors (βAR) belong to the large family of G protein-coupled receptors that form the interface between the sympathetic nervous and cardiovascular systems. G protein-coupled receptors undergo adaptation to repeated or prolonged agonist stimulation, which is termed desensitization. Significant βAR desensitization occurs with the development of cardiac hypertrophy and heart failure, and uncoupling of βARs and defects in this pathway might be primary elements underlying the transition from compensated to uncompensated cardiac failure. Decreasing the level of myocardial βARK1 in established heart failure is a novel approach to improving impaired βAR receptor function, and potentially alter the pathogenesis of this disease. (Korean Circulation J 2005;35:485-492)
No takes yet. Share an insight, caveat, or question.
Dong‐Ju Choi (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: